Saudi Journal of Gastroenterology

DEBATE
Year
: 2007  |  Volume : 13  |  Issue : 4  |  Page : 200--203

Albumin use is beneficial in cirrhotic patients


Faisal M Sanai1, Paul J Marotta2 
1 Division of Hepatology, Department of Medicine, Riyadh Military Hospital, Riyadh, Saudi Arabia
2 Multiorgan Transplant Unit, London Health Sciences Center, London, United Kingdom

Correspondence Address:
Faisal M Sanai
Department of Medicine, Riyadh Military Hospital, P. O. Box 7897, Riyadh - 11159
Saudi Arabia

There are several indications for the use of albumin in patients with decompensated cirrhosis and its role has existed in clinical practice for many decades. While the drug enjoys immense popularity, it yet attracts intensive debate amongst clinicians and pharmacologists alike. Regardless of its pharmacological properties, its clinical use in cirrhotic patients has its fair share of proponents and opponents. At present, in the setting of cirrhosis this debate centers around the treatment of spontaneous bacterial peritonitis, in patients with ascites treated with large volume paracentesis, and in those with hepato-renal syndrome. With the evolving evidence it has become imperative to shed old dogmas and address this issue in the light of evidence-based medicine. This article gives a representative view of albumin use in the above conditions across both sides of the clinical divide.


How to cite this article:
Sanai FM, Marotta PJ. Albumin use is beneficial in cirrhotic patients.Saudi J Gastroenterol 2007;13:200-203


How to cite this URL:
Sanai FM, Marotta PJ. Albumin use is beneficial in cirrhotic patients. Saudi J Gastroenterol [serial online] 2007 [cited 2021 Nov 27 ];13:200-203
Available from: https://www.saudijgastro.com/article.asp?issn=1319-3767;year=2007;volume=13;issue=4;spage=200;epage=203;aulast=Sanai;type=0